Nov 28 (Reuters) - Arcturus Therapeutics Holdings Inc ARCT.O :
- JAPAN'S MINISTRY OF HEALTH, LABOUR AND WELFARE APPROVES CSL AND ARCTURUS THERAPEUTICS' ARCT-154
- ARCT-154 IS A SELF-AMPLIFYING MRNA (SA-MRNA) COVID-19 VACCINE FOR INITIAL VACCINATION AND BOOSTER FOR ADULTS 18 YEARS AND OLDER
(([email protected];))
News: CSL CSL Says Japan's Ministry Of Health, Labour And Welfare Approves Arct-154
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$270.68 |
Change
2.760(1.03%) |
Mkt cap ! $131.5B | |||
| Open | High | Low | Value | Volume |
| $268.49 | $271.88 | $268.22 | $38.82M | 143.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 111 | $270.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $270.69 | 35 | 3 |
View Market Depth
| Last trade - 11.36am 28/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |